These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 28053526)

  • 1. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
    Song Y; Li Y; Xu Q; Liu Z
    Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell microenvironment stimuli-responsive controlled-release delivery systems based on mesoporous silica nanoparticles.
    Zhu CL; Wang XW; Lin ZZ; Xie ZH; Wang XR
    J Food Drug Anal; 2014 Mar; 22(1):18-28. PubMed ID: 24673901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution and present scenario of multifunctionalized mesoporous nanosilica platform: A mini review.
    Bao BQ; Le NH; Nguyen DHT; Tran TV; Pham LPT; Bach LG; Ho HM; Nguyen TH; Nguyen DH
    Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():912-928. PubMed ID: 30033325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticles in nanomedicine applications.
    Manzano M; Vallet-Regí M
    J Mater Sci Mater Med; 2018 May; 29(5):65. PubMed ID: 29737405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized mesoporous silica materials for controlled drug delivery.
    Yang P; Gai S; Lin J
    Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalized mesoporous silica nanoparticles and biomedical applications.
    Hoang Thi TT; Cao VD; Nguyen TNQ; Hoang DT; Ngo VC; Nguyen DH
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():631-656. PubMed ID: 30889738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-Time Monitoring of ATP-Responsive Drug Release Using Mesoporous-Silica-Coated Multicolor Upconversion Nanoparticles.
    Lai J; Shah BP; Zhang Y; Yang L; Lee KB
    ACS Nano; 2015 May; 9(5):5234-45. PubMed ID: 25859611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
    Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH and Glutathione Dual-Responsive Dynamic Cross-Linked Supramolecular Network on Mesoporous Silica Nanoparticles for Controlled Anticancer Drug Release.
    Li QL; Xu SH; Zhou H; Wang X; Dong B; Gao H; Tang J; Yang YW
    ACS Appl Mater Interfaces; 2015 Dec; 7(51):28656-64. PubMed ID: 26633741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetism, Ultrasound, and Light-Stimulated Mesoporous Silica Nanocarriers for Theranostics and Beyond.
    Lin FC; Xie Y; Deng T; Zink JI
    J Am Chem Soc; 2021 Apr; 143(16):6025-6036. PubMed ID: 33857372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in silica based nanoparticles for targeted cancer therapy.
    Yang Y; Yu C
    Nanomedicine; 2016 Feb; 12(2):317-32. PubMed ID: 26706409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DPP-Cu
    Chen W; Ma M; Lai Q; Zhang Y; Liu Z
    Curr Med Chem; 2023; 30(28):3249-3260. PubMed ID: 36221869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells.
    Tran VA; Vo VG; Shim K; Lee SW; An SSA
    Int J Nanomedicine; 2020; 15():7667-7685. PubMed ID: 33116494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-cargo selectively controlled release based on a pH-responsive mesoporous silica system.
    Gui W; Wang W; Jiao X; Chen L; Wen Y; Zhang X
    Chemphyschem; 2015 Feb; 16(3):607-13. PubMed ID: 25492672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large pore mesoporous silica nanomaterials for application in delivery of biomolecules.
    Knežević NŽ; Durand JO
    Nanoscale; 2015 Feb; 7(6):2199-209. PubMed ID: 25583539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.
    Castillo RR; Lozano D; González B; Manzano M; Izquierdo-Barba I; Vallet-Regí M
    Expert Opin Drug Deliv; 2019 Apr; 16(4):415-439. PubMed ID: 30897978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.